Volume 63; Issue 3

Cancer Chemotherapy and Pharmacology

Volume 63; Issue 3

1

Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas

Rafael B. Erlich, Danny Rickwood, William B. Coman, Nicholas A. Saunders, Alexander Guminski

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 475 KB

english, 2009

2

A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic cell transplantation patients

Erica L. Woodahl, Joanne Wang, Shelly Heimfeld, Brenda M. Sandmaier, Paul V. O’Donnell, Brian Phillips, Linda Risler, David K. Blough, Jeannine S. McCune

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 297 KB

english, 2009

3

Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study

Jaime Feliu, Jose Luis Firvida, Javier Castro, Catherina Madroñal, Angeles Rodríguez-Jaráiz, Mercedes Salgado, Cristóbal Belda-Iniesta, Enrique Casado, Jesús García-Mata, Manuel González-Barón, For th

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 280 KB

english, 2009

4

Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2′-deoxycytidine

Maryse Lemaire, Louise F. Momparler, Noël J.-M. Raynal, Mark L. Bernstein, Richard L. Momparler

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 313 KB

english, 2009

5

Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapy

Ahmad Awada, Martine J. Piccart, Suzanne F. Jones, Ronald A. Peck, Thierry Gil, David Lebwohl, Chi-Yuan Wu, Howard A. Burris

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 358 KB

english, 2009

6

Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer

Hyo Jin Lee, Do Yeun Cho, Ji Chan Park, Sang Byung Bae, Kyu Taek Lee, In Sung Cho, Chang Soon Han, Suk Young Park, Hwan Jung Yun, Samyong Kim

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 276 KB

english, 2009

7

Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis

Hee Yeon Seo, Dae Sik Kim, Yoon Seok Choi, Hwa Jung Sung, Kyong Hwa Park, In Keun Choi, Seok Jin Kim, Sang Cheul Oh, Jae Hong Seo, Chul Won Choi, Byung Soo Kim, Sang Won Shin, Yeul Hong Kim, Jun Suk K

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 290 KB

english, 2009

8

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine

Smitha S. Krishnamurthi, Joanna M. Brell, Charles L. Hoppel, Merrill J. Egorin, Karen C. Weaver, Xiaolin Li, Stephen T. Ingalls, Eleanor G. Zuhowski, Mark D. Schluchter, Afshin Dowlati, Matthew M. Coo

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 487 KB

english, 2009

9

Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin®, in resistant solid tumor malignancies

Paula M. Fracasso, Joel Picus, Jonathan D. Wildi, Sherry A. Goodner, Allison N. Creekmore, Feng Gao, Ramaswamy Govindan, Matthew J. Ellis, Benjamin R. Tan, Gerald P. Linette, ChauHwei J. Fu, Helen S.

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 396 KB

english, 2009

10

Carbamazepine induces bioactivation of cyclophosphamide and thiotepa

Corine Ekhart, Sjoerd Rodenhuis, Jos H. Beijnen, Alwin D. R. Huitema

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 286 KB

english, 2009

11

Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma

Ju Hyun Shim, Joong-Won Park, Byung Ho Nam, Woo Jin Lee, Chang-Min Kim

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 390 KB

english, 2009

12

A Bayesian population PK–PD model for ispinesib/docetaxel combination-induced myelosuppression

Steven J. Kathman, Daphne H. Williams, Jeffrey P. Hodge, Mohammed Dar

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 267 KB

english, 2009

13

A dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in the fasted and fed state

C. L. O’Bryant, C. H. Lieu, S. Leong, R. Boinpally, M. Basche, L. Gore, K. Leonardi, M. K. Schultz, S. Hariharan, L. Chow, S. Diab, A. Gibbs, S. G. Eckhardt

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 508 KB

english, 2009

14

ASNA1, an ATPase targeting tail-anchored proteins, regulates melanoma cell growth and sensitivity to cisplatin and arsenite

O. Hemmingsson, Y. Zhang, M. Still, P. Naredi

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 422 KB

english, 2009

15

Pharmacokinetic profile of imatinib mesylate andN-desmethyl-imatinib (CGP 74588) in children with newly diagnosed Ph+ acute leukemias

Elena Marangon, Marco Citterio, Federica Sala, Elena Barisone, Alma Augusta Lippi, Carmelo Rizzari, Andrea Biondi, Maurizio D’Incalci, Massimo Zucchetti

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 235 KB

english, 2009

16

Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients

Koji Okabayashi, Hirotoshi Hasegawa, Yoshiyuki Ishii, Takashi Endo, Hiroki Ochiai, Tetsuro Kubota, Yuko Kitagawa

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 392 KB

english, 2009

17

Pathologic complete response after palliative 3rd line chemotherapy with capecitabine alone in metastatic colorectal cancer

Hyeon Jin Cho, Su-Jung Kim, Sun Young Kim, Hye-Suk Han, Yong Sang Hong, Seong Hoon Kim, Seok-Byung Lim, Kyung Hae Jung, Hee Jin Chang, Eun Kyung Hong

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 447 KB

english, 2009

18

Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age

Dae Young Zang, Dae Hyun Yang, Hae Wan Lee, Se Won Hwang, Hun Ho Song, Joo Young Jung, Jung Hye Kwon, Hyo Jung Kim, Jung Han Kim, Sa Rah Park, Min-Jeong Kim, Kyung Mi Jang, Choong Kee Park, Jong Hyeok

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 384 KB

english, 2009

19

Enterohepatic recirculation model of irinotecan (CPT-11) and metabolite pharmacokinetics in patients with glioma

Islam R. Younis, Samuel Malone, Henry S. Friedman, Larry J. Schaaf, William P. Petros

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 371 KB

english, 2009

20

MDA-MB-435 cells are from melanoma, not from breast cancer

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 119 KB

english, 2009

21

Effect of antacid on imatinib absorption

Brian A. Sparano, Merrill J. Egorin, Robert A. Parise, Jennifer Walters, Kristin A. Komazec, Robert L. Redner, Jan H. Beumer

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 231 KB

english, 2009

22

Detection of complete response to imatinib mesylate (Glivec®/Gleevec®) with 18F-FDG PET/CT for low-grade endometrial stromal sarcoma

Mehmet Emin Kalender, Alper Sevinc, Mustafa Yilmaz, Coskun Ozsarac, Celalettin Camci

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 414 KB

english, 2009

23

Detection of complete response to imatinib mesylate (Glivec®/Gleevec®) with 18F-FDG PET/CT for low-grade endometrial stromal sarcoma

Mehmet Emin Kalender, Alper Sevinc, Mustafa Yilmaz, Coskun Ozsarac, Celalettin Camci

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 119 KB

english, 2009

24

Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer

Yoon Jae Kim, Seungmin Bang, Jeong Youp Park, Seung Woo Park, Jae Bock Chung, Si Young Song

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 263 KB

english, 2009

25

Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer

Hee Man Kim, Seungmin Bang, Jeong Youp Park, Jinsil Seong, Si Young Song, Jae Bock Chung, Seung Woo Park

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 310 KB

english, 2009

26

Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand

Henriette Gourdeau, James B. McAlpine, Maxime Ranger, Bryan Simard, Francois Berger, Francis Beaudry, Chris M. Farnet, Pierre Falardeau

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 98 KB

english, 2009